Figure 5.
Waterfall plots of individual relative changes in (A) non-normalized total lesion PSMA (TLP), (B) liver-normalized TLP (TLP-LR) and (C) parotid-normalized TLP (TLP-PR) after medication with enzalutamide. Black—enzalutamide-naïve patients. Grey—patients with previous enzalutamide treatment. Values over 100% were cropped for simplification.
